GlaxoSmithKline

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Public

Established: 1929-01-01

Employees: 70.2K

Market Cap: $90B

Website: http://www.gsk.com

Introduction: GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Clinical Trials

Assessment of Clinical Consistency of Three Production Lots of GSK Biologicals' HRV Vaccine

Phase 3

Completed

Conditions: Infections, Rotavirus

Interventions: Biological: Placebo
Biological: Rotarix

First Posted Date: 2008-09-23

Last Posted Date: 2016-09-07

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 854

Registration Number: NCT00757770

Locations: GSK Investigational Site

Evaluation of Pneumococcal Vaccine Formulations in Elderly

Phase 1

Completed

Conditions: Infections, Streptococcal

Interventions: Biological: Pneumococcal vaccine GSK2189241A
Biological: Pneumo 23™

First Posted Date: 2008-09-19

Last Posted Date: 2017-05-10

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 168

Registration Number: NCT00756067

Locations: 🇸🇪
GSK Investigational Site, Örebro, Sweden

Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy

Phase 3

Completed

Conditions: Sarcoma, Soft Tissue

Interventions: Drug: Placebo
Drug: PAZOPANIB

First Posted Date: 2008-09-16

Last Posted Date: 2013-08-22

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 369

Registration Number: NCT00753688

Locations: 🇬🇧
GSK Investigational Site, Sheffield, United Kingdom

Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants

Phase 4

Completed

Conditions: Hepatitis B
Diphtheria
Poliomyelitis
Haemophilus Influenzae Type b
Acellular Pertussis
Tetanus

Interventions: Biological: Infanrix™ hexa

First Posted Date: 2008-09-16

Last Posted Date: 2019-11-27

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 224

Registration Number: NCT00753649

Locations: 🇨🇦
GSK Investigational Site, Truro, Nova Scotia, Canada

Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older

Phase 3

Completed

Conditions: Influenza

Interventions: Biological: GSK Bio's influenza vaccine GSK2186877A
Biological: Fluarix TM

First Posted Date: 2008-09-16

Last Posted Date: 2018-06-08

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 43695

Registration Number: NCT00753272

Locations: 🇬🇧
GSK Investigational Site, Waterloo, Liverpool, United Kingdom

Experimental Dentifrice Remineralization/Fluoride Uptake in an in Situ Model

Phase 2

Completed

Conditions: Dental Erosion

Interventions: Drug: NaF Dentifrice
Other: Placebo Dentifrice
Drug: NaF/ KNO3/isopentane Dentifrice
Drug: NaF/KNO3 Dentifrice

First Posted Date: 2008-09-15

Last Posted Date: 2016-12-08

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 20

Registration Number: NCT00752089

Effect of Orlistat in Body Composition

Phase 4

Completed

Conditions: Obesity
Overweight

Interventions: Drug: Orlistat
Drug: Placebo

First Posted Date: 2008-09-15

Last Posted Date: 2013-03-08

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 131

Registration Number: NCT00752726

Locations: 🇺🇸
Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States
🇸🇪
Sahlgrenska Academy, Goteborg, West Gothland, Sweden
🇺🇸
Duke Clinical Research Unit, Durham, North Carolina, United States